Plain-English translation of NCT06964802 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether soaking your feet in cold water during paclitaxel chemotherapy can help prevent a common side effect called peripheral neuropathy—nerve damage that causes numbness, tingling, and pain in the hands and feet. Researchers will compare two groups: one using cold salt water foot baths and another using cold plain water foot baths, against a control group receiving standard care. The goal is to see if either type of foot bath can reduce your risk of developing this painful nerve damage.
Paclitaxel is an effective cancer-fighting drug, but it frequently causes peripheral neuropathy as a side effect, which can be painful and interfere with daily life. Currently, there is no proven way to prevent this damage, so researchers are testing whether simple cold water foot baths might help protect patients from developing this complication.
You likely qualify if…
You likely don't qualify if…
You will attend 12 weeks of paclitaxel chemotherapy treatment. Depending on which group you are assigned to, you will either soak your feet in cold salt water or cold plain water for 10 minutes, four times during each 3-hour chemotherapy session—or you will receive standard care with no foot baths. Before each treatment cycle, researchers will examine your feet using simple tests and ask you about any numbness, tingling, or pain you are experiencing. At the end of 12 weeks, you will have a final evaluation of your nerve function.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Turkey (Türkiye)